Compass Therapeutics, Inc. · NASDAQ:CMPX

Orbimed Advisors LLC reported a 8.90% stake in Compass Therapeutics, Inc. (Schedule 13D/A)

Event Aug 13, 2025 · Filed Aug 15, 2025

Orbimed Advisors LLC reported a 8.90% stake in Compass Therapeutics, Inc., 15,219,994 shares, with active intent on Aug 13, 2025. Filed Aug 15, 2025 (Schedule 13D/A).

Stake
8.90%
Shares
15,219,994
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC8.90%15,219,994
ORBIMED CAPITAL GP V LLC8.90%15,219,994

Source

View original at SEC

Related